Form 4 for BSX Boston Scientific
Accepted 2023-09-21 00:00:00 ET · period of report 2023-09-20 · accession 0001225208-23-009007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-21 | 2023-09-20 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $55.00 | -15.9K | 198.0K | -7% | -$872.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-20 | S | D | 15,867 | $55.00 | 197,992 | D | — | — |